 |
The 130th Annual Meeting of APHA |
|
The 130th Annual Meeting of APHA |
3116.0: Monday, November 11, 2002: 10:30 AM-12:00 PM | |||
Oral | |||
| |||
| The purpose of this session is to highlight important activities in birth defects and developmental disabilities epidemiology. A number of different research areas and methodologies will be highlighted. Specific presentations will: examine the role of important risk factors like smoking and birthweight on childhood disability; highlight the efforts to prevent birth defects and developmental disabilites by targeting lead poisoning and folic acid prevention; examine trends in birth defects suveillance in international settings; and examine national policies for ultrasound screening to identify fetal anomalies prenatally. | |||
| Learning Objectives: 1. Identify the key factors in birth defects surveillance. 2. Recognize the impact of public health prevention efforts in lead and folic acid. 3. Identify the importance of birth weight in childhood disability. | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | |||
| Coleen Boyle | |||
| R. Louise Floyd, DSN, RN Gilberto Chavez, MD, MPH | |||
| Effects of prenatal exposure to tobacco and low birthweight on the development of childhood disabilities Marygrace E. Yale, PhD, Keith G. Scott, PhD, Carrie Lazurus, BA, Craig A. Mason, PhD, Antonio Gonzalez, BS | |||
| Major congenital anomalies at birth in Benghazi, Libyan Arab Jamahiriya Ratan Singh, MD, Omar Ehmida Al-Sudani, OE | |||
| Preventing birth defects: A nationwide effort to train future health professionals about folic acid Sandra Maldague, MPH, Carol Hogue, PhD, MPH, Janis Biermann, MS | |||
| Shifting the lead belt: Changes in the prevalence of childhood lead poisoning in Philadelphiathy Richard E Tobin, MS, MPA | |||
| Targeted fetal anomaly scanning in Edinburgh: Implications for policy change Julie D Clark, BSc MPH, Sue Payne, Dr, Peter Donnelly, MD MPH MBA FRCP | |||
| Withdrawn -- Pregnancy outcomes in women taking anti-asthmatic medications in the Georgia Medicaid population George J. Joseph, MS, Jeffrey A. Kotzan, PhD, William E. Wade, PharmD | |||
| Organized by: | Maternal and Child Health | ||
| Endorsed by: | Epidemiology; School Health Education and Services | ||
| CE Credits: | CME, Health Education (CHES), Nursing, Pharmacy, Social Work | ||